PILA PHARMA AB
556966-4831ActiveClinical stage biotech developing an oral obesity and diabetes treatment.
Oversikt
- 1–4
- Ansatte
- 750–999t SEK
- Omsetning
- 2014
- Grunnlagt
Beskrivelse
PILA PHARMA is a clinical stage biotechnology company focused on innovative drug development. The organization is pioneering the development of XEN-D0501, an oral TRPV1-antagonist. This drug candidate is being positioned as a potential first-in-class treatment for serious conditions like obesity and...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556966483101
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAbarceo Pharma AB
5–9 ansatteDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
AcroPharma AB (publ)
0 ansatteDeveloping innovative preventive therapeutics for major human diseases.
DiaBridge AB
0 ansatteDeveloping breakthrough drugs targeting DNA repair for cancer and inflammation.
Synartro AB
1–4 ansatteDeveloping sustained local injection treatments for osteoarthritis pain relief.
Transient Pharma AB
0 ansatteDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
Utforsk mer
Spørsmål om PILA PHARMA AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo